Ferulic Acid Methyl Ester Attenuates Cerebral Ischemia-Reperfusion Injury in Rats by Modulating PI3K/HIF-1α/VEGF Signaling Pathway
Peijie Zhou,Shangshang Yu,Xuan Wang,Xiaofei Zhang,Dongyan Guo,Chongbo Zhao,Jiangxue Cheng,Jing Wang,Jing Sun
DOI: https://doi.org/10.2147/jir.s473665
IF: 4.5
2024-09-01
Journal of Inflammation Research
Abstract:Peijie Zhou, &ast Shangshang Yu, &ast Xuan Wang, &ast Xiaofei Zhang, Dongyan Guo, Chongbo Zhao, Jiangxue Cheng, Jing Wang, Jing Sun Department of Pharmaceutics, College of Pharmacy, The Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine, Shaanxi Provincial Engineering Technology Research Center for Traditional Chinese Medicine Decoction Pieces, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jing Sun, Email Background: Cerebral ischaemia-reperfusion injury (CIRI) could worsen the inflammatory response and oxidative stress in brain tissue. According to previous studies, ferulic acid methyl ester (FAME), as the extract with the strongest comprehensive activity in the traditional Chinese medicine Huang Hua oil dot herb, has significant anti-oxidative stress and neuroprotective functions, and can effectively alleviate CIRI, but its mechanism of action is still unclear. Methods: Firstly, the pharmacological effects of FAME were investigated by in vitro oxidative stress and inflammatory experiments. Secondly, evaluate the therapeutic effects of FAME in the treatment of CIRI by brain histopathological staining and cerebral infarct area by replicating the in vivo MACO model. Thirdly, RNA-Seq and network pharmacology were utilized to predict the possible targets and mechanisms of FAME for CIRI at the molecular level. Finally, the expression of key target proteins, as well as the key regulatory relationships were verified by molecular docking visualization, Western Blotting and immunohistochemistry. Results: The results of in vitro experiments concluded that FAME could significantly reduce the content of TNF-α, IL-1β and ROS, inhibiting COX-2 and iNOS protein expression in cells(p< 0.01). FAME was demonstrated to have anti-oxidative stress and anti-inflammatory effects. The results of in vivo experiments showed that after the administration of FAME, the area of cerebral infarction in rats with CIRI was reduced, the content of Bcl-2 and VEGF was increased(p< 0.05). Network pharmacology and RNA-Seq showed that the alleviation of CIRI by FAME may be through PI3K-AKT and HIF-1 signaling pathway. Enhanced expression of HIF-1α, VEGF, p-PI3K, p-AKT proteins in the brain tissues of rats in the FAME group was verified by molecular docking and Western Blotting. Conclusion: FAME possesses significant anti-inflammatory and anti-oxidative stress activities and alleviates CIRI through the PI3K/HIF-1α/VEGF signaling pathway. Keywords: ferulic acid methyl ester, cerebral ischemia-reperfusion injury, WGCNA, RNA-Seq, network pharmacology, molecular docking techniques Graphical Stroke, an acute cerebrovascular disease characterized by disruption of energy supply, neuronal death and brain tissue damage due to insufficient blood supply to the brain caused by rupture or blockage of blood vessels in the brain. 1 Ischemic stroke accounts for about 60% to 70% of all strokes, 2 has a higher incidence than hemorrhagic stroke, and is considered one of the most prevalent central nervous system (CNS) diseases. 3 Clinical therapeutics for acute ischemic stroke mainly include two ways: arterial and venous thrombolysis and mechanical resection embolization. Among them, arterial thrombolysis and mechanical resection embolization have higher rates of restoring blood flow in cerebral arteries compared with intravenous thrombolysis. 4 However, it is worth noting that cerebral ischemia-reperfusion injury (CIRI) can occur at any time, regardless of treatment, and is one of the risk factors secondary to essential perfusion therapy for ischemic stroke that needs to be urgently addressed. 5 Currently, neurocytoprotective agent therapy is emerging as an emerging avenue for cerebral ischaemia-reperfusion injury. According to previous studies, the key targets include HIF-1A, Nrf2 and MPO, which effectively inhibit oxidative stress and inflammation in brain tissues through different mechanisms of action and alleviate the secondary damage of brain tissues caused by CIRI. Pathophysiological process of CIRI involves various mechanisms including oxidative stress, neuroinflammation, mitochondrial dysfunction, 6 intracellular calcium overload and programmed cell death. 7 These processes are interrelated and together lead to neuronal death, brain tissue damage and severe neurological deficits. Currently, drugs commonly used in the treatment of CIRI include free radical scavengers, excitatory amino acid antagonists, calcium channel blockers, and anti-inflammatory drugs. 8 However, due to the compl -Abstract Truncated-
immunology